Maneka Mirchandaney analyst

Currently out of the existing stock ratings of Maneka Mirchandaney, 9 are a BUY (69.23%), 4 are a HOLD (30.77%).

Maneka Mirchandaney

Work Performance Price Targets & Ratings Chart

Analyst Maneka Mirchandaney, carries an average stock price target met ratio of 50% that have a potential upside of 24.26% achieved within 123 days.

Maneka Mirchandaney’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 12-Feb-2024.

Wall Street Analyst Maneka Mirchandaney

Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.

Average potential price target upside

CRNX Crinetics Pharmaceuticals INCY yte INKT Mink Therapeutics SGEN Seagen VRDN Viridian Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$81

$43.54 (116.23%)

$81

1 months 11 days ago
(13-Jan-2025)

14/17 (82.35%)

$42.02 (107.80%)

265

Buy

$87

$49.54 (132.25%)

$80

2 months 8 days ago
(16-Dec-2024)

9/15 (60%)

$32.37 (59.25%)

394

Buy

$90

$52.54 (140.26%)

$65

5 months 8 days ago
(16-Sep-2024)

3/6 (50%)

$36.06 (66.85%)

131

Buy

$73

$35.54 (94.87%)

$74

6 months 15 days ago
(09-Aug-2024)

5/7 (71.43%)

$25.36 (53.23%)

146

Buy

$54

$16.54 (44.15%)

$47

7 months 15 days ago
(09-Jul-2024)

9/9 (100%)

$5.77 (11.96%)

183

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Maneka Mirchandaney?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?